Answers are grounded in this paper and cite their sources.
This report demonstrates cost avoidance due to OPAT plan reconciliation among patients in value-based care models, highlighting its financial impact.
We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.
No takes yet. Share an insight, caveat, or question.
Ross et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: